Founded in 1995, Intuitive Surgical (ISRG) is the global pioneer and leader in robotic-assisted minimally invasive surgery. Its flagship da Vinci Surgical System has revolutionized the industry, with over 20 million procedures performed worldwide as of 2026. The company recently launched the da Vinci 5, featuring 10,000x the computing power of previous models and groundbreaking force-feedback technology. Complementing its surgical platforms is the Ion system for lung biopsies. Operating on a robust “razor-and-blade” model, Intuitive generates over 75% of its $10B+ annual revenue from recurring instruments and services across 70+ countries.
Here are some articles to give you a basic understanding of the company:
Intuitive Surgical – background and history
Below is a list of articles for the company:
-
Intuitive Surgical – FY25 results
Analysis of Intuitive Surgical (ISRG) Q4 2025 Performance Based on the latest financial results, here is a deep dive into the company’s strategic position and outlook: Revenue Drivers and Product Momentum Profitability and Financial Health 2026 Outlook and Risk Factors Conclusion Intuitive Surgical closed 2025 with strong momentum, specifically through the successful early ramp of…
-
Intuitive Surgical – History and Competitions
Here is the history of Intuitive Surgical (ISRG) categorized into four distinct development stages: 1995-2004: Foundations and Early Breakthroughs This period was defined by the transition from military research to a commercial medical reality. 2005-2013: Global Expansion and Technological Iteration During this phase, the company refined its technology and proved its commercial viability globally. 2014-2023:…